These innovations herald developments in colon cancer detection.
Third Eye Panoramic Device from Avantis
While colonoscopies are the gold standard for detecting colorectal cancers, even experienced physicians can miss up to 24 percent of adenomas due to blind spots caused by folds in the colon.
The Avantis Third Eye Panoramic device is designed to work around the limits of a forward-facing colonoscopy camera by attaching two additional cameras directed laterally on the left and right sides. The device clips to the outside of a colonoscope at the tip, leaving the instrument channel open and free to suction debris. The images from all three cameras are projected on one monitor. This seamless, panoramic view increases visibility behind folds and flexures.
Developers believe the Third Eye Panoramic device, currently under review by the FDA, will provide an intuitive, effective addition to a standard colonoscope.
Colonoscopy Helper App
Image courtesy of ColonoscopyHelper.com
While preparing for a colonoscopy can be tedious, it is also crucial; improper preparation can lead to an inaccurate or delayed test. The new Colonoscopy Helper app is designed to make the multiple steps of colonoscopy prep convenient and easy to remember.
Providing 13 reminders over 10 days, the app is designed to guide users through the entire colonoscopy process, both before and after the procedure. It has a master schedule customized to the user’s needs — including the date and time of the colonoscopy — and offers text, video and illustrations to guide the patient through each step. The app also reminds users about any necessary medication adjustments before and after a colonoscopy. In addition, after a colonoscopy, it alerts users to symptoms that require immediate medical care.
The Colonoscopy Helper is available for free on iPhone and Android devices.
SOMATOM Force CT System
Image courtesy of Siemens Healthcare
For colon cancer patients, staying ahead of any occult lesions is vital — and may entail multiple imaging tests. Keeping radiation dosages low while also reaching the desired image clarity can be challenging.
The SOMATOM Force CT system from Siemens was designed to provide the benefits of low-dose radiation to a wider range of patients, including those with colon cancer. Among other benefits, the SOMATOM Force uses the latest technology to provide 4-D imaging at half the normal dose of radiation. For patients, that means follow-up imaging studies can be delivered “at a continually low dose to enable more decisive treatment and post-therapy evaluations,” according to Siemens.
The SOMATOM Force was approved by the FDA in April.